Ever Fortune. AI Co

Ever Fortune. AI Co P/TBV

The Price to Tangible Book Value (P/TBV) of Ever Fortune. AI Co (6841.TWO) as of Oct 21, 2026 is 3.34. In the previous year, Price to Tangible Book Value (P/TBV) was 3.12 — a change of 7.23% (higher).

P/TBV

3.34

YoY

7.23%

Last updated:

Price to Tangible Book Value (P/TBV) of Ever Fortune. AI Co is 2025 3.34 . Price to Tangible Book Value (P/TBV) of Ever Fortune. AI Co was 2024 3.12 . It decreases by 7.23% higher compared to the previous year.

The Ever Fortune. AI Co P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
42.41 TWD
Jan 1, 2020
3.59 TWD
Jan 1, 2021
3.80 TWD
Jan 1, 2022
3.48 TWD
Jan 1, 2023
2.96 TWD
Jan 1, 2024
3.12 TWD
Jan 1, 2025
3.34 TWD
The Ever Fortune. AI Co P/TBV history
YEARP/TBVYoY
3.34+7.23%
3.12+5.34%
2.96-15.05%
3.48-8.46%
3.80+5.88%
3.59-91.53%
42.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Fortune. AI Co Stock analysis

What does Ever Fortune. AI Co do? Ever Fortune.AI Co., Ltd. generates revenue through the sale of medical AI software products and customized technology solutions. The company offers medical big data platforms, cloud biomedical services, and AI-driven tools such as the radiographic bone age-assisted interpretation system, ultrasound breast tumor auxiliary classification system, and CT liver cancer metastasis risk management system. These products target healthcare providers, hospitals, and medical institutions seeking advanced diagnostic and analytical capabilities. The firm's focus on specialized medical AI applications ensures consistent demand from clients requiring precision in radiology, oncology, and cardiology. The company's revenue streams include the provision of medical AI data analysis services and tailored AI technology solutions for healthcare facilities. Products like the liver fibrosis evaluation system and irregular cardiac fibrillation interpretation system are designed to address specific clinical needs, enhancing diagnostic accuracy. Healthcare organizations, particularly those in radiology and cardiology departments, purchase these tools to improve patient outcomes and operational efficiency. Ever Fortune.AI's business model centers on delivering high-value AI solutions for medical diagnostics, with a portfolio that includes both standardized products and custom-developed systems. The firm's offerings cater to hospitals and medical institutions looking to integrate AI into their diagnostic workflows. By focusing on niche medical applications, the company establishes itself as a specialized provider in the healthcare technology sector. Ever Fortune. AI Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ever Fortune. AI Co stock

Price to Tangible Book Value (P/TBV) of Ever Fortune. AI Co is 3.34 in 2025.

Price to Tangible Book Value (P/TBV) of Ever Fortune. AI Co changed from 3.12 to 3.34, representing a 7.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Ever Fortune. AI Co since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Ever Fortune. AI Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ever Fortune. AI Co

All Key Metrics — Ever Fortune. AI Co